Daniel W. Wilkey
Papers
1
Total Citations
41
H-Index
1
About
Daniel W. Wilkey is a prominent researcher in the fields of proteomics and diabetic nephropathy, with a focus on identifying biomarkers for kidney disease progression. His major contributions center on the application of mass spectrometry-based proteomics to uncover molecular signatures of renal decline, particularly in type 1 diabetes. His most-cited work, "Plasma kininogen and kininogen fragments are biomarkers of progressive renal decline in type 1 diabetes" (2013, 41 citations), demonstrated that specific fragments of kininogen in plasma could serve as predictive indicators of worsening kidney function, offering a non-invasive tool for early intervention. This study has been influential in advancing the understanding of how proteolytic pathways contribute to diabetic complications. Wilkey’s research has helped bridge the gap between basic proteomic discovery and clinical application, providing a foundation for personalized monitoring of renal health. His work is highly regarded for its methodological rigor and translational potential, making him a key figure in the effort to improve outcomes for patients with diabetes at risk of kidney failure.
Research Focus
Key Achievements
Top Papers
- 1